Ted William Karkus - 13 Jan 2023 Form 4 Insider Report for ProPhase Labs, Inc. (PRPH)

Role: CEO & CHAIRMAN, Director, 10%+ Owner
Signature: /s/ Ted Karkus
Issuer symbol: PRPH
Transactions as of: 13 Jan 2023
Net transactions value: -$2,628,002
Form type: 4
Filing time: 17 Jan 2023, 15:37:46 UTC
Previous filing: 18 Oct 2022
Next filing: 02 Feb 2023
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	PRPH	Common Stock, par value $0.005	Options Exercise	$360,000	+600,000	+20%	$0.6000^*	3,671,318	13 Jan 2023	Direct	F1
transaction	PRPH	Common Stock, par value $0.005	Tax liability	$2,988,002	-319,231	-8.7%	$9.36	3,352,087	13 Jan 2023	Direct	F1
holding	PRPH	Common Stock, par value $0.005						100,000	13 Jan 2023	By Son

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	PRPH	Option (right to buy)	Options Exercise	$0	-600,000	-55%	$0.000000	500,000	13 Jan 2023	Common Stock	600,000	$0.6000	Direct	F1, F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	On January 13, 2023, the Reporting Person acquired net 280,769 shares of common stock upon the exercise of stock options to purchase 600,000 shares of common stock, less 319,231 shares of common stock withheld to cover the exercise price and applicable taxes.
F2	The option vested in 35 equal monthly installments of 63,888 shares on the 1st day of each month beginning on March 1, 2018 (the "Initial Vesting Date"), and one monthly installment of 63,920 shares on the 1st day of the 36th month following the Initial Vesting Date, as described in a stock option award agreement by and between the Issuer and the Reporting Person, dated as of February 19, 2018.